The AI stack for pharmacoepidemiology.
A Few of Our Customers and Partners
Next-generation pharmacoepidemiology.
Verantos is transforming pharmacoepidemiology, combining the highest quality real-world data, curation, and clinical inference with agentic AI to generate high-validity evidence.
The Verantos pharmacoepidemiology stack advances evidence generation for R&D, clinical development, commercial, regulatory, safety, and post-marketing use cases, all from one rigorous foundation.
Verantos Curation Platform
Pairs clinical annotators with AI agents to label data, train extraction and inference models, and produce fully structured curated data sets from medical records.
Learn moreVerantos Pragmatic Registry
Disease-specific, study-ready data sets that capture the clinical richness of routine care, without the scale constraints of consented registries.
Learn moreVerantos Evidence Platform
End-to-end study design and execution with conversational and agentic AI, taking epidemiologists from study question to results at a fraction of the time and cost.
Learn more
A trusted partner.
Verantos is a trusted partner to the world's most successful life sciences organizations. The Verantos epidemiology and informatics teams, supported by forward-deployed engineers, partner with the world's top biopharma researchers to design evidence solutions for the most challenging problems.
High-validity evidence generation
Full-lifecycle study services: protocol design through analysis, reporting, and peer-reviewed publication.
Learn moreCuration and AI model development
Custom models for extraction, imputation, and clinical inference, developed in accordance with FDA AI guidance.
Learn moreA track record of cutting-edge research.
TRUST and VERIFY: FDA-funded demonstration projects operationalizing data richness and reliability for regulatory-grade real-world evidence.
Supported by the FDA, the National Institutes of Health, and the National Science Foundation.
What’s new at Verantos.
Product launches, conferences, and peer-reviewed results: something new most months.
All newsReady to advance your evidence program?
Speak with our team about how the Verantos pharmacoepidemiology stack can accelerate your timeline.